Open Access Ketamine and propofol in combination induce neuroapoptosis and down-regulate the expression of N-methyl-D-aspartate glutamate receptor NR2B subunit in rat forebrain culture

 Download
(PDF 1,366 kb)
 
Download Article:

Abstract:

Background and objective: Ketamine has always been used in combination with propofol in paediatric patients. Ketamine interacts with N-methyl-D-aspartate glutamate receptor to exert its biologic actions. The NMDA receptor NR2B subunit is expressed at nearly adult level during forebrain development in the cortex and considered as the major type of functional NMDA receptor in the central nervous system. This study aimed to investigate whether ketamine or ketamine in combination with propofol induces apoptosis and regulates the expression level of NMDA receptor NR2B subunit in rat forebrain culture. Methods: Rat primary forebrain cultures were exposed to different concentrations of ketamine (1 μM, 10 μM, 20 μM) or 20 μM ketamine plus 5 μM propofol on the 6th day for 12 h. Cell viability was examined by 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide assay. Caspase-3 activity was measured and apoptotic morphology was examined by Hoechst dye staining. The expression of NMDA receptor NR2B subunit at mRNA and protein level was determined by qPCR and Western blot, respectively. Results: Ketamine (10 μM and 20 μM) or 20 μM ketamine plus 5 μM propofol resulted in a significant decrease in cell viability, and a significant increase in caspase-3 activity and apoptosis of primary rat forebrain culture. The expression of NMDA receptor NR2B subunit at both mRNA and protein levels were down-regulated by administration of ketamine (1 μM, 10 μM and 20 μM) and 20 μM ketamine plus 5 μM propofol. Conclusion: Ketamine (10 μM or 20 μM) alone or in combination with propofol (20 μM ketamine plus 5 μM propofol) induces neuroapoptosis and down-regulates of NMDA receptor NR2B subunit in rat forebrain culture.

Document Type: Research Article

DOI: http://dx.doi.org/10.1691/ph.2011.1501

Publication date: October 1, 2011

More about this publication?
  • Pharmazie is one of the world's leading pharmaceutical journals. As a peer-reviewed scientific journal, DiePharmazie is regularly indexed in Current Contents/Life Sciences, Excerpta Medica, Analytical Abstracts, International Pharmaceutical Abstracts, Beilstein Current Facts in Chemistry, Chemical Engineering and Biotechnology Abstracts (CEABA) and Science Citation Index.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more